Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -5.18 is 173% below its 3-year average of -1.90, near the low end of its 3-year range (-5.18–-0.72).
87.34% below its 12-month average of -2.77.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.32.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 6 comparable quarters.
EARNINGS PER SHARE (EPS)
-5.18
EARNINGS PER SHARE (EPS) AVG TTM
-2.77
EARNINGS PER SHARE (EPS) AVG 3Y
-1.90
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-87.34%
CURRENT VS 3Y AVG
-172.99%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MapLight Therapeutics, Inc.
Market Cap
$396.78M
Earnings Per Share (EPS)
-5.18
TTM Avg
-2.77
3Y Avg
-1.90
5Y Avg
N/A
Market Cap
$390.32M
Earnings Per Share (EPS)
-3.79
TTM Avg
-4.17
3Y Avg
-5.22
5Y Avg
-3.47
Market Cap
$406.69M
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.81
3Y Avg
-2.62
5Y Avg
-2.62
Market Cap
$386.82M
Earnings Per Share (EPS)
-1.54
TTM Avg
-2.79
3Y Avg
-2.67
5Y Avg
-2.08
Market Cap
$410.53M
Earnings Per Share (EPS)
-4.63
TTM Avg
-6.16
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$407.54M
Earnings Per Share (EPS)
-5.51
TTM Avg
-4.26
3Y Avg
-3.91
5Y Avg
-2.87
Market Cap
$409.35M
Earnings Per Share (EPS)
-2.08
TTM Avg
-1.97
3Y Avg
-1.74
5Y Avg
-0.94
Market Cap
$409.89M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$410.57M
Earnings Per Share (EPS)
0.50
TTM Avg
0.08
3Y Avg
-0.25
5Y Avg
-0.31
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $396.78M | -5.18 | -2.77 | -1.90 | N/A |
| REGENXBIO Inc. (RGNX)vs › | $390.32M | -3.79 | -4.17 | -5.22 | -3.47 |
| Carlsmed, Inc. (CARL)vs › | $406.69M | -1.36 | -1.81 | -2.62 | -2.62 |
| Orthofix Medical Inc. (OFIX)vs › | $386.82M | -1.54 | -2.79 | -2.67 | -2.08 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $410.53M | -4.63 | -6.16 | -6.16 | -6.16 |
| Neurogene Inc. (NGNE)vs › | $407.54M | -5.51 | -4.26 | -3.91 | -2.87 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $409.35M | -2.08 | -1.97 | -1.74 | -0.94 |
| Shoulder Innovations, Inc. (SI)vs › | $409.89M | -1.71 | -1.36 | -1.12 | -1.12 |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.57M | 0.50 | 0.08 | -0.25 | -0.31 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $383.62M | -2.94 | -3.49 | -2.70 | -2.28 |
Trailing EPS (TTM)
$-5.18
Forward EPS (Est.)
$-4.94
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.66 |
| 2024-12-31 | -1.87 |
| 2023-12-31 | -1.34 |
| 2022-12-31 | -0.72 |
